ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2172

Automating the Curation and Summarization of Rheumatology Fellowship Applications using Generative AI Agents and Transformer Models

Andrew Trotter1, Angelo Gaffo2, Amanda Alexander3, John Osborne1 and Jeffrey Curtis4, 1University of Alabama at Birmingham, Birmingham, AL, 2Division of Rheumatology and Clinical Immunology, University of Alabama, Birmingham, AL, USA; Birmingham VA Medical Center, Birmingham, AL, USA, Birmingham, AL, 3University of Alabama at Birmingham, Homewood, AL, 4Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL

Meeting: ACR Convergence 2025

Keywords: Data Management, education, medical, Health Services Research

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2159–2194) Professional Education Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The rheumatology medical fellowship application review process requires significant time from program directors and faculty who manually analyze dozens of multi-part applications each year. A typical year may yield ~200 applicants and require 50+ hours for fellowship program director(s) to pre-screen them and decide which should be offered interviews. Each application typically includes a 40-page PDF document and a structured Excel export from (ERAS) with > 2,500 columns of data per applicant. The possibility that artificial intelligence (AI) and large language models (LLMs) might concisely summarize fellow applications, protect applicant privacy, and highlight criteria to make subsequent interview decisions remains unexplored.

Methods: We developed an AI pipeline to help automate the fellowship screening process. It uses GPT-4o combined with GPU-accelerated optical character recognition (OCRs) to reduce manual review time. For each applicant, the two de-identified text files were concatenated and fed into an AI agent that uses GPT-4o to generate 1-2 page summaries aligned to specific feature domains (e.g., Clinical Potential, Awards, USMLE scores, Research Output) developed as part of the project and curated by subject matter experts (e.g. program directors and clinical faculty) in Table 1.The output of the pipeline was a concise narrative summary that reduced each ~40 page application to 1-2 pages. A GPT 4o-mini HIPAA-complaint Azure instance was then used to analyze a 169-document corpus of previously reviewed fellowship applications. Reduction in the amount of time for the narrative pre-review was the primary endpoint for evaluation. As a secondary metric, each applicant was scored on a scale of 1-100, where a score of at last 70 would receive an interview to align with institutional reviewing capacity. The scores were then compared to the manually annotated corpus, relating the scores to applicants who received interviews and those who did not receive interviews, versus what the model predicted.

Results: Across the 2017-2024 application cycles, and after implementation of the AI pipeline, the amount of manual effort to pre-screen fellow applicants for a single annual cycle (n = 180 fellow applicants) was decreased from approximately 50 hours to approximately 2 hours total The analysis finished in 2 minutes and 26 seconds using the Azure OpenAI API and is scalable to larger datasets. Overall accuracy compared to who was offered interviews was 0.69 with recall of 0.59 (Figure 1), with the confusion matrix shown in Figure 2.

Conclusion: Results indicate that this novel pipeline can assist with rheumatology fellowship screening and save dramatic amounts of human reviewer time. Ongoing refinement is underway to improve model performance compared to the both the interview outcome and subsequent program director and faculty reviews, and to make this tool more widely available.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: A. Trotter: None; A. Gaffo: Atom, 2, Avalo Therapeutics, 2, PK Med, 2, Scilex, 2, Sobi, 2; A. Alexander: None; J. Osborne: None; J. Curtis: AbbVie, 2, 5, Amgen, 2, 5, AstraZeneca, 2, 5, Bendcare, 2, 5, Eli Lilly, 2, 5, Genentech, 2, 5, Glaxo Smith Kline, 2, 5, Horizon, 2, 5, Janssen, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, Scipher medicine, 2, 5, SetPoint, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Trotter A, Gaffo A, Alexander A, Osborne J, Curtis J. Automating the Curation and Summarization of Rheumatology Fellowship Applications using Generative AI Agents and Transformer Models [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/automating-the-curation-and-summarization-of-rheumatology-fellowship-applications-using-generative-ai-agents-and-transformer-models/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/automating-the-curation-and-summarization-of-rheumatology-fellowship-applications-using-generative-ai-agents-and-transformer-models/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology